Pediatrix Medical Group Inc (MD) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Pediatrix Medical Group Inc   (NYSE: MD)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare

Select the Financial Report: Select the Period:


Description of Pediatrix Medical Group Inc's Business Segments


Segments

Pediatrix Medical Group Inc. is a prominent provider of physician services specifically designed for newborns and their families. The organization operates through two primary segments focused on delivering specialized care:

1. Neonatal Care:
This segment is dedicated to offering expert medical care to premature and critically ill newborns. Pediatrix Medical Group operates neonatal intensive care units (NICUs) in various hospitals across the United States. Their commitment to neonatal care encompasses the deployment of advanced medical technologies, the delivery of innovative treatment protocols, and the application of exceptional medical expertise. The neonatology team typically includes pediatricians with specialized training in neonatology, neonatal nurses, respiratory therapists, nutrition specialists, and other allied health professionals.

2. Pediatric Cardiology:
Pediatrix Medical Group provides thorough cardiac care for infants, children, and young adults with congenital or acquired heart conditions. This segment includes a wide array of services ranging from diagnostic assessments—such as echocardiograms, electrocardiograms, and stress tests—to comprehensive medical management and minimally invasive interventions. The pediatric cardiology team is comprised of skilled cardiologists, pediatric nurses, and support staff, all dedicated to delivering tailored care for each patients unique needs.

Products and Services

Pediatrix Medical Group offers an extensive menu of products and services tailored to meet the complex needs of newborns and pediatric patients, including:

1. Neonatal and Pediatric Care:
- Intensive Care and Support: Providing round-the-clock monitoring and care for premature and critically ill newborns, including state-of-the-art interventions.
- Respiratory Support: Offering specialized treatments for respiratory distress, including non-invasive and invasive ventilation strategies.
- Nutrition Management: Implementing tailored feeding strategies, including parenteral and enteral nutrition, to support the growth and development of critically ill infants.
- Developmental Interventions: Engaging in therapies aimed at promoting optimal neurodevelopment and mitigating long-term adverse outcomes, such as occupational and physical therapy.

2. Pediatric Cardiology Services:
- Diagnostic Testing: Comprehensive evaluations through various tests to identify and monitor cardiac conditions.
- Medical Management: Offering medication management and routine follow-ups for patients with chronic heart conditions.
- Minimally Invasive Procedures: Utilizing advanced techniques such as catheter-based interventions to treat specific cardiac anomalies without the need for open-heart surgery.

3. Hospital-Based Services:
Pediatrix partners with hospitals, enhancing their capability to provide specialized physician services for newborns and pediatric patients. This partnership includes training and support for hospital staff, ensuring they are equipped to handle complex cases with the latest knowledge and techniques.

4. Telehealth Services:
- Virtual Consultations: Facilitating remote consultations for patients who may face challenges in traveling to healthcare facilities.
- Remote Monitoring: Utilizing technology to track patient health metrics from home, allowing for timely interventions when necessary.
- Online Resources: Providing educational materials and support resources for families, empowering them to manage their childrens health more effectively.

5. Research and Innovation:
Pediatrix Medical Group actively participates in research aimed at advancing neonatal and pediatric care. This includes conducting clinical trials, collaborating with renowned researchers in the field, and continually investing in cutting-edge technology to enhance patient outcomes and improve the overall quality of care.

Conclusion

In summary, Pediatrix Medical Group Inc. is dedicated to providing an extensive range of high-quality medical services for newborns and pediatric patients. Their focus on specialized care—through segments such as neonatal care and pediatric cardiology—along with a commitment to innovation and research, positions the organization as a trusted leader in healthcare for young patients across the United States. Their comprehensive approach ensures that families receive both compassionate and expertly delivered medical care during crucial times in their childrens lives.


Composition of Pediatrix Medical Group Inc Revenues by Segments

 
Health Care Patient Service    168.94 % of total Revenue
Hospitals Contracts    28.34 % of total Revenue
Product and Service Other    0.35 % of total Revenue

Q2 three months ended (Jun 30 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
Health Care Patient Service 824.05 168.94 %
Hospitals Contracts 138.23 28.34 %
Product and Service Other 1.70 0.35 %
Total 487.78 100 %




Q2 three months ended (Jun 30 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
Health Care Patient Service - -
Hospitals Contracts - -
Product and Service Other - -
Total 4.04 % 2.43 %




Q2 three months ended (Jun 30 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Total 39.84 8.17 %




Q2 three months ended (Jun 30 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total 1.48 % 34.73 %




Annual Report on Pediatrix Medical Group Inc Divisions, Sales by Country

 
Net patient service revenue   Net patient service revenue Segment contribution to total sales 85.2 % of total Revenue
Hospital contract administrative fees   Hospital contract administrative fees Segment contribution to total sales 14.17 % of total Revenue
Other revenue   Other revenue Segment contribution to total sales 0.64 % of total Revenue
Contracted Managed Care   Contracted Managed Care Segment contribution to total sales 0 % of total Revenue
Government   Government Segment contribution to total sales 0 % of total Revenue
Other Third-Parties   Other Third-Parties Segment contribution to total sales 0 % of total Revenue
Private-Pay Patients   Private-Pay Patients Segment contribution to total sales 0 % of total Revenue


Twelve months ended 2025
MD s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
Total 1,913.85 100 %
Net patient service revenue 1,630.52 85.2 %
Hospital contract administrative fees 271.13 14.17 %
Other revenue 12.21 0.64 %
Contracted Managed Care 0.00 0 %
Government 0.00 0 %
Other Third-Parties 0.00 0 %
Private-Pay Patients 0.00 0 %


Twelve months ended 2025
MD s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total 165.39 8.64 %

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Total -4.92 % -
Net patient service revenue -5.4 % -
Hospital contract administrative fees -5.43 % -
Other revenue 363.97 % -
Contracted Managed Care 0 % -
Government 0 % -
Other Third-Parties 0 % -
Private-Pay Patients 0 % -
Neonatology and Other Pediatric Subspecialties - -
Maternal-Fetal Medicine - -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.